Harzklinikum Dorothea Christiane Erxleben GmbH
Quedlinburg, Germany
General hospital in Quedlinburg, Saxony-Anhalt
Ditfurter Weg 24, 06484 Quedlinburg
About Harzklinikum Dorothea Christiane Erxleben GmbH
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Abbott Medical Devices
5
Daiichi Sankyo, Inc.
2
AGO Research GmbH
1
Boston Scientific Corporation
1
EuMelaReg gGmbH
1
SRH Wald-Klinikum Gera GmbH
1
Sun Pharmaceutical Industries Limited
1
University Hospital Tuebingen
1
Clinical Trials at Harzklinikum Dorothea Christiane Erxleben GmbH
During the past decade, Harzklinikum Dorothea Christiane Erxleben GmbH conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on
average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Reduction of Inappropriate Implantable Cardioverter Defibrillator (ICD) Therapies in Primary Prevention Patients
2009-08-01
2013-01-01
Completed
543
Effectiveness and Reliability of VectSelect™ Feature for Avoidance of Phrenic Nerve Stimulation in Cardiac Resynchronisation Therapy (CRT) Patients
2008-03-01
2011-08-01
Completed
132
Selected Site Pacing to Avoid Phrenic Nerve Stimulation in Cardiac Resynchronization Patients With Quadripolar Left Ventricular Leads
2011-11-01
2014-06-01
Completed
337
Evaluation of Optimal Treatment With Bevacizumab in Patients With Platinum-sensitive Recurrent Ovarian Cancer
2013-05-01
2021-01-01
Completed
682
Optimizing Pacing Therapy by Using Multi-Programmable Pulse Generators for Cardiac Resynchronization Pacing (CRT-P)
2015-05-01
2017-03-01
Completed
64
Edoxaban Treatment in Routine Clinical Practice for Patients With Non Valvular Atrial Fibrillation
2015-08-01
2022-04-13
Completed
13,980
Neoadjuvant Vismodegib in Patients With Large and/or Recurrent Resectable Basal Cell Carcinoma
2017-01-01
2021-01-01
Completed
40
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Harzklinikum Dorothea Christiane Erxleben GmbH" #1 sponsor was "Abbott Medical Devices" with 5 trials, followed by "Daiichi Sankyo, Inc." with 2 trials
sponsored, "AGO Research GmbH" with 1 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored and "EuMelaReg gGmbH"
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Harzklinikum Dorothea Christiane Erxleben GmbH"
#1 collaborator was "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator, "Australia New Zealand Gynaecological Oncology Group" with 1 trials as a collaborator, "Daiichi Sankyo Deutschland GmbH" with 1 trials as a collaborator and "ICON plc" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Harzklinikum Dorothea Christiane Erxleben GmbH
According to Clinical.Site data, the most researched conditions in "Harzklinikum Dorothea Christiane Erxleben GmbH" are
"Atrial Fibrillation" (3 trials), "Basal Cell Carcinoma" (2 trials), "Heart Failure" (2 trials), "Brain Metastases" (1 trials) and "Cardiac Arrhythmias" (1 trials). Many other conditions were trialed in "Harzklinikum Dorothea Christiane Erxleben GmbH" in a lesser frequency.
Clinical Trials Intervention Types at Harzklinikum Dorothea Christiane Erxleben GmbH
Most popular intervention types in "Harzklinikum Dorothea Christiane Erxleben GmbH" are "Drug" (6 trials), "Device" (5 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Edoxaban" (2 trials), "Bevacizumab" (1 trials), "CRT-P indicated patients" (1 trials), "Carboplatin" (1 trials) and "Confirm Rx ICM insertion procedure" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Harzklinikum Dorothea Christiane Erxleben GmbH
The vast majority of trials in "Harzklinikum Dorothea Christiane Erxleben GmbH" are
12 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Harzklinikum Dorothea Christiane Erxleben GmbH
Currently, there are NaN active trials in "Harzklinikum Dorothea Christiane Erxleben GmbH".
undefined are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Harzklinikum Dorothea Christiane Erxleben GmbH,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Harzklinikum Dorothea Christiane Erxleben GmbH, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".